Pharmacoeconomic analysis of the use of a fixed combination of tiotropium bromide and olodaterol as maintenance therapy in patients with chronic obstructive pulmonary disease in the Russian Federation

Pharmacoeconomic analysis of the use of a fixed combination of tiotropium bromide and olodaterol as maintenance therapy in patients with chronic obstructive pulmonary disease in the Russian Federation

Objective: to evaluate the pharmacoeconomic effectiveness of the use of a fixed double combination of tiotropium bromide + olodаterol in order to treat chronic obstructive pulmonary disease (COPD) in comparison with less expensive monotherapy with long-acting beta-2-agonists (LABA) or long-acting an...

Full description

Saved in:
Bibliographic Details
Main Authors: S. К. Zyryanov, I. N. Dyakov
Format: Article
Language:Russian
Published: IRBIS LLC 2022-07-01
Series:Фармакоэкономика
Subjects:
chronic obstructive pulmonary disease
copd
gold d
tiotropium bromide + olodaterol
monotherapy
combination therapy
budget impact
exacerbations
long-acting bronchodilator
long-acting m-cholinolytic
real clinical practice
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/688
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items